Yukiko Namba

501 total citations
22 papers, 342 citations indexed

About

Yukiko Namba is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Molecular Biology. According to data from OpenAlex, Yukiko Namba has authored 22 papers receiving a total of 342 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pulmonary and Respiratory Medicine, 6 papers in Physiology and 5 papers in Molecular Biology. Recurrent topics in Yukiko Namba's work include Lung Cancer Treatments and Mutations (6 papers), Lung Cancer Diagnosis and Treatment (4 papers) and Renal cell carcinoma treatment (3 papers). Yukiko Namba is often cited by papers focused on Lung Cancer Treatments and Mutations (6 papers), Lung Cancer Diagnosis and Treatment (4 papers) and Renal cell carcinoma treatment (3 papers). Yukiko Namba collaborates with scholars based in Japan, United States and China. Yukiko Namba's co-authors include Kazuhisa Takahashi, Shinichi Sasaki, Shinsaku Togo, Kiyoshi YOSHIZAWA, T. Kaneda, Akio Ejima, Shigeru Tominaga, Takahiro Hayashi, Kotaro Kadoya and Junko Watanabe and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Oncotarget.

In The Last Decade

Yukiko Namba

20 papers receiving 325 citations

Peers

Yukiko Namba
Yuxian Guo China
Hsi-Wen Yeh United States
Hong Im Kim United States
Oliver Delgado United States
Reid Loveless United States
I. Kubota Japan
Sandra Lettlová Czechia
Carlos Saus Spain
Jiao Liu United States
D. Veissière France
Yuxian Guo China
Yukiko Namba
Citations per year, relative to Yukiko Namba Yukiko Namba (= 1×) peers Yuxian Guo

Countries citing papers authored by Yukiko Namba

Since Specialization
Citations

This map shows the geographic impact of Yukiko Namba's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yukiko Namba with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yukiko Namba more than expected).

Fields of papers citing papers by Yukiko Namba

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yukiko Namba. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yukiko Namba. The network helps show where Yukiko Namba may publish in the future.

Co-authorship network of co-authors of Yukiko Namba

This figure shows the co-authorship network connecting the top 25 collaborators of Yukiko Namba. A scholar is included among the top collaborators of Yukiko Namba based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yukiko Namba. Yukiko Namba is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Namba, Yukiko, Atsushi Yamashita, Etsuko Kobayashi, et al.. (2025). A collaborative study to disseminate the clinical practice of diagnosing and managing Birt–Hogg–Dubé syndrome in Japan. Respiratory Investigation. 63(5). 877–884.
2.
Horinouchi, Hidehito, Shogo Nomura, Satoshi Igawa, et al.. (2023). Reconsidering the Cutoff Value for Sensitive and Refractory Relapses in Extensive-Stage SCLC in the Era of Immunotherapy. Journal of Thoracic Oncology. 19(2). 325–336. 9 indexed citations
3.
4.
Goto, Yasushi, Kodai Kawamura, Tatsuro Fukuhara, et al.. (2023). Health Care Resource Use Among Patients with Advanced Non–Small Cell Lung Cancer in Japan, 2017–2019. Current Therapeutic Research. 99. 100712–100712. 2 indexed citations
5.
Suzuki, Yohei, et al.. (2022). Multiple Types of Taste Disorders among Patients with COVID-19. Internal Medicine. 61(14). 2127–2134. 5 indexed citations
6.
Shukuya, Takehito, Ryo Ko, Yusuke Okuma, et al.. (2022). Clinical Significance of Tumor Markers for Advanced Thymic Carcinoma: A Retrospective Analysis from the NEJ023 Study. Cancers. 14(2). 331–331. 2 indexed citations
7.
Kadoya, Kotaro, Shinsaku Togo, Yukiko Namba, et al.. (2019). Specific Features of Fibrotic Lung Fibroblasts Highly Sensitive to Fibrotic Processes Mediated via TGF-β–ERK5 Interaction. Cellular Physiology and Biochemistry. 52(4). 822–837. 12 indexed citations
8.
Sasaki, Shinichi, et al.. (2019). Management of skin sarcoidosis with minocycline monotherapy. Respirology Case Reports. 7(4). e00413–e00413. 10 indexed citations
9.
Enomoto, Yutaka, Yukiko Namba, Keiko Mitani, et al.. (2019). A case of Birt-Hogg-Dubé syndrome implying reduced or no wild-type folliculin without mutated protein is pathogenic. European Journal of Medical Genetics. 63(4). 103820–103820. 3 indexed citations
10.
Watanabe, Junko, Shinsaku Togo, Yukiko Namba, et al.. (2018). Clinical features of squamous cell lung cancer with anaplastic lymphoma kinase (ALK)-rearrangement: a retrospective analysis and review. Oncotarget. 9(35). 24000–24013. 19 indexed citations
11.
Togo, Shinsaku, Ichiro Nagata, Kazue Shimizu, et al.. (2017). Lung adenocarcinoma expressing receptor for advanced glycation end-products with primary systemic AL amyloidosis: a case report and literature review. BMC Cancer. 17(1). 22–22. 11 indexed citations
12.
Namba, Yukiko, Shinsaku Togo, Kotaro Kadoya, et al.. (2017). Combination of glycopyrronium and indacaterol inhibits carbachol-induced ERK5 signal in fibrotic processes. Respiratory Research. 18(1). 46–46. 8 indexed citations
13.
14.
Togo, Shinsaku, Kazue Shimizu, Takuo Hayashi, et al.. (2015). Variation in the expression levels of predictive chemotherapy biomarkers in histological subtypes of lung adenocarcinoma: an immunohistochemical study of tissue samples.. PubMed. 8(9). 10523–33. 1 indexed citations
15.
Murakami, Akiko, Rina Ohashi, Ryo Koyama, et al.. (2012). [Efficacy of erlotinib after gefitinib administration in patients with non-small cell lung cancer].. PubMed. 39(9). 1357–61.
16.
Komeno, Yukiko, Junya Ako, Yoshiaki Shimada, et al.. (2001). A Case of Gliomatosis Cerebri in an Elderly Woman.. Nippon Ronen Igakkai Zasshi Japanese Journal of Geriatrics. 38(4). 540–543. 2 indexed citations
17.
18.
Bando, Toshikazu, Yukiko Namba, & Kozo Shishido. (1997). Lipase-mediated asymmetric construction of 2-arylpropionic acids: enantiocontrolled syntheses of S-naproxen and S-ibuprofen. Tetrahedron Asymmetry. 8(13). 2159–2165. 17 indexed citations
19.
Yokoi, Isao, Yukiko Namba, Hideaki Kabuto, et al.. (1996). Relationship between structure and inhibitory effect of arginine analogues on neuronal nitric oxide synthase activity. Neurochemical Research. 21(10). 1187–1192. 3 indexed citations
20.
Namba, Yukiko, Kiyoshi YOSHIZAWA, Akio Ejima, Takahiro Hayashi, & T. Kaneda. (1969). Coenzyme A- and Nicotinamide Adenine Dinucleotide-dependent Branched Chain α-Keto Acid Dehydrogenase. Journal of Biological Chemistry. 244(16). 4437–4447. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yuxian Guo Breakdown of academic impact, for papers by Hsi-Wen Yeh Breakdown of academic impact, for papers by Hong Im Kim Breakdown of academic impact, for papers by Oliver Delgado Breakdown of academic impact, for papers by Reid Loveless Breakdown of academic impact, for papers by I. Kubota Breakdown of academic impact, for papers by Sandra Lettlová Breakdown of academic impact, for papers by Carlos Saus Breakdown of academic impact, for papers by Jiao Liu Breakdown of academic impact, for papers by D. Veissière
Rankless by CCL
2026